Sunday, February 2, 2025
Facebook Linkedin Twitter
HomeIndustriesBiotechnology

Biotechnology

Biotechnology

Nuvalent Announces First Patient Dosed in ARROS-1 Phase 1/2 Clinical Trial of NVL-520, its Novel ROS1-selective Inhibitor

PR Newswire -
Nuvalent, Inc., a biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer, announced that the first patient has been dosed...
Biotechnology

Washington State Department of Health Invests in Esper to Transform Policymaking and Boost Citizen Engagement

PR Newswire -
Esper is pleased to announce its recent partnership with the Washington State Department of Health (DOH) to help the agency achieve its goals of...
Biotechnology

Biohaven To Collaborate with KU Leuven to Advance TRPM3 Antagonists for Pain Treatment

PR Newswire -
Biohaven Therapeutics Ltd., a subsidiary of Biohaven Pharmaceutical Holding Company Ltd., along with CD3 and LICR at KU Leuven, announced that they have entered...
Biotechnology

Laekna Therapeutics and Innovent Biologics Obtain IND Approval for Combination Therapy For Tumor patients

PR Newswire -
Laekna Therapeutics announced that the investigational new drug (IND) application of a combination therapy for the phase 1/2 clinical trial in patients with solid...
Biotechnology

Optimvia and Ginkgo Bioworks Announce Partnership to Manufacture Biosynthetic Heparin

PR Newswire -
Optimvia, a biotechnology company specializing in engineering enzymes and their cofactors to synthesize complex therapeutic molecules, and Ginkgo Bioworks, the leading horizontal platform for...
1...292293294...317Page 293 of 317
0FansLike
0FollowersFollow
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us